Global Next-Generation Sequencing on Drug Development Market

Sep 2023| BIO246A| BCC Publishing
Sample Report

Report Highlights

The global next-generation sequencing (NGS) market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a compound annual growth rate (CAGR) of 17.7% for the forecast period of 2023 to 2028.

Report Includes

  • 52 data tables and 39 additional tables
  • An overview of the global markets for next-generation sequencing on drug development
  • Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of next-generation sequencing on drug development market by product, service, end-user type, and region
  • Examination of the key drivers and constraints that will shape the market for next-generation sequencing on drug development and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and subsegments
  • Coverage of recent advances, emerging technologies, and developments of the industry
  • Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
  • Profiles of the key companies of the industry, including 10x Genomics, Bio-Rad Laboratories Inc., Oxford Nanopore Technologies, Qiagen and Takara Bio Inc.

Report Scope

The scope of this report includes NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS in drug development are given for 2020, 2021, 2022, 2023 and 2028.

This report reviews the NGS technologies and explains why NGS is important in drug development. It then discusses some of the significant research initiatives that impact NGS. The main market-driving forces are also discussed.

This report examines the markets by product type, end user and region. This report provides market data and forecasts for NGS by product type, including instruments, consumables and services for drug development.

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the Rest of the World.

BCC Research summarizes the main industry acquisitions and strategic alliances from Jan. 2020, through Dec. 2022, including key alliance trends.

Frequently Asked Questions (FAQs)

The next-generation sequencing on drug development market is projected to grow from $1.1 billion in 2022 to $2.9 billion in 2028 at a compound annual growth rate (CAGR) of 17.7% during the forecast period.
The key factors driving the growth of the next-generation sequencing on drug development market include increasing research and development activities utilizing NGS technologies, the rise in technological advancements, the shift towards precision medicine, and the Growing demand to NGS for designing individualized medicine for cancer patients is boosting the growth of the next-generation sequencing on the drug development market.
The next-generation sequencing on the drug development market is segmented based on product type, by end-user, and by region.
The consumables segment will dominate the next-generation sequencing on drug development market by the end of 2028.
Key companies in the market include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Oxford Nanopore Technologies plc., F Hoffmann-La Roche AG, Takara Bio, PacBio., Tecan Group, 10X Genomics, Bio-Rad Laboratories, Inc., PerkinElmer, BGI Genomics, Psomagen, Inc., Integrated DNA technologies, CD Genomics, New England Biolabs, and Promega Corp.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $1.1 billion
Market size forecast $2.9 billion
Growth rate CAGR of 17.7% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Product Type, End-User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
Key Market Drivers
  • Increasing R&D Activities using NGS technologies
  • Increase in Healthcare Expenditure
  • Technological Advancements in Sequencing Platforms
  • Shift Towards Precision Medicine
  • Growing demand of NGS for Designing Individualized Medicine to Cancer Patients
  • High Accuracy and Low Cost
Companies studied
  • 10X GENOMICS
  • AGILENT TECHNOLOGIES INC.
  • BGI (BEIJING GENOMICS INSTITUTE)
  • BIO-RAD LABORATORIES INC.
  • CD GENOMICS
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • MICRONOMA
  • NEW ENGLAND BIOLABS
  • OXFORD NANOPORE TECHNOLOGIES
  • PACIFIC BIOSCIENCES OF CALIFORNIA INC.
  • PERKINELMER INC.
  • PROMEGA CORP.
  • PSOMAGEN INC.
  • PRECISION FOR MEDICINE, FORMERLY APOCELL
  • QIAGEN
  • ROCHE HOLDING AG
  • THERMO FISHER SCIENTIFIC INC.
  • TAKARA BIO INC.
  • TECAN GROUP LTD.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: Global Next-Generation Sequencing on Drug Development Market177 $5,500 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights5$250Free
Chapter- 3: Market Overview33$1,031Free
Chapter- 4: Market Dynamics8$250Free
Chapter- 5: NGS in Drug Development by Product Type8$250Free
Chapter- 6: NGS Market in Drug Development by End User4$125Free
Chapter- 7: NGS Market in Drug Development by Region11$344Free
Chapter- 8: Sustainability of NGS in Drug Development: An ESG Perspective10$313Free
Chapter- 9: Emerging Technologies and Developments3$94Free
Chapter- 10: Patent Analysis15$469Free
Chapter- 11: M&A and Funding Outlook3$94Free
Chapter- 12: Competitive Landscape3$94Free
Chapter- 13: Company Profiles68$2,125Free
Chapter- 14: Appendix: Acronyms1$31Free
Global Next-Generation Sequencing on Drug Development Market

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS